Ross Givens
Chief Market Strategist
Ross Givens is a veteran trader with over 15 years of experience and a former VP at a major Wall Street investment bank. Specializing in small-cap stocks and momentum-driven plays, Ross identifies high-probability setups before they hit the mainstream. As Lead Strategist at Traders Agency, he has guided hundreds of successful trades and developed multiple flagship publications.
The Biggest Market Rotation Of 2026 Has Started... I'm Buying These 2 Stocks
The 2026 market rotation is here — NASDAQ down 3% while biotech and quantum computing surge. IOVA and LAES are breaking out as capital flees semiconductors
The Pentagon Just Gave These 3 Stocks $1.2 BILLION (Nobody Noticed)
Rare earth supply chain stocks just got $1.2B in Pentagon funding — and it wasn't MP Materials. Three under-the-radar names are cashing the checks.
The AI Gold Rush Is Here... These 3 Stocks Sell The Shovels
AI picks and shovels stocks are the smartest trade in the boom. Atkore, Belden, and Methode supply every data center at a fraction of the crowd's 40x valua
The Pentagon Could Hand This $6 Stock $200 Million
A Pentagon defense contract small cap could hand a $6 stock a $200M loitering munition award. Which company holds exclusive Israeli combat drone rights?
Wall Street Is Chasing SpaceX... Smart Money Is Buying These 4 Stocks
Smart money stock picks are beating the SpaceX IPO pop. These 4 backdoor plays in AI infrastructure and oil shipping offer real upside without chasing hype
SpaceX Is Trading... Here's EXACTLY When I'd Buy and Sell
SpaceX is now trading -- here's when to buy SpaceX shares for the lowest price. Lockup expirations create a mid-August window smart traders won't miss.
The Government Is Erasing $39 Trillion In Debt... Here's How To Profit
The government erasing national debt through inflation is already underway. Here's how debt monetization works and which mining stocks stand to benefit mos
Does the SpaceX IPO Mark the “Top” for Tech?
The SpaceX IPO is going LIVE today. What’s going to happen next – and does the massive hype mark the “top” for the market? Find out inside.
AI Agents Are Coming... These 3 Stocks Could Go PARABOLIC
Agentic AI stocks are entering a new phase as 1.4B knowledge workers replace chatbots with autonomous agents. These 3 backdoor infrastructure plays could e
Could the SpaceX IPO End the Pullback?
The pullback continues. But the question on people’s minds is – could the SpaceX IPO end the pullback? Ross investigates.
The FDA Said NO Twice... Then Everything Changed for This $1 Stock
FDA drug rejection reversal almost never happens — but it did for Outlook Therapeutics. OTLK trades under $1 with an FDA decision due in roughly 60 days.
Could This Tech Selloff Spread to the Rest of the Market?
The tech selloff continues. Could it lead to a broader market selloff? Ross explores the situation inside.
Stop watching.
Start winning.
50,000+ traders get our daily brief before the market opens.
You're subscribed!
Check your inbox.
Free. No spam. Unsubscribe anytime.
